As of March 26, 2026, the CDC reports 1,575 confirmed measles cases across 32 U.S. jurisdictions in 2026, with 94% tied to 16 outbreaks—primarily in South Carolina (nearly 1,000 cases), Texas, Utah, and Florida—fueling rapid transmission in under-vaccinated communities where 92% of patients are unvaccinated or of unknown status. This surge, accelerated by the virus's high basic reproduction number (12-18), marks the fastest growth since 1992, surpassing early-year records and risking loss of U.S. measles elimination status. Hospitalizations stand at 5% with no deaths. Traders should watch weekly CDC updates (next expected early April) and state vaccination campaigns, as ongoing outbreaks could add hundreds more cases by April 30 resolution.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket · ОбновленоMeasles cases in U.S. by April 30?
Measles cases in U.S. by April 30?
$66,415 Объем
$66,415 Объем
30 апр. 2026 г.
1800
93%
1900
72%
2000
41%
2100
13%
2200
10%
$66,415 Объем
$66,415 Объем
30 апр. 2026 г.
1800
$13,899 Объем
93%
1900
$19,366 Объем
72%
2000
$22,832 Объем
41%
2100
$1,515 Объем
13%
2200
$8,803 Объем
10%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, the CDC reports 1,575 confirmed measles cases across 32 U.S. jurisdictions in 2026, with 94% tied to 16 outbreaks—primarily in South Carolina (nearly 1,000 cases), Texas, Utah, and Florida—fueling rapid transmission in under-vaccinated communities where 92% of patients are unvaccinated or of unknown status. This surge, accelerated by the virus's high basic reproduction number (12-18), marks the fastest growth since 1992, surpassing early-year records and risking loss of U.S. measles elimination status. Hospitalizations stand at 5% with no deaths. Traders should watch weekly CDC updates (next expected early April) and state vaccination campaigns, as ongoing outbreaks could add hundreds more cases by April 30 resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Mar 27, 2026, 1:49 PM ET
Объем
$66,415Дата окончания
30 апр. 2026 г.Открытие рынка
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, the CDC reports 1,575 confirmed measles cases across 32 U.S. jurisdictions in 2026, with 94% tied to 16 outbreaks—primarily in South Carolina (nearly 1,000 cases), Texas, Utah, and Florida—fueling rapid transmission in under-vaccinated communities where 92% of patients are unvaccinated or of unknown status. This surge, accelerated by the virus's high basic reproduction number (12-18), marks the fastest growth since 1992, surpassing early-year records and risking loss of U.S. measles elimination status. Hospitalizations stand at 5% with no deaths. Traders should watch weekly CDC updates (next expected early April) and state vaccination campaigns, as ongoing outbreaks could add hundreds more cases by April 30 resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$66,415Дата окончания
30 апр. 2026 г.Открытие рынка
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...As of March 26, 2026, the CDC reports 1,575 confirmed measles cases across 32 U.S. jurisdictions in 2026, with 94% tied to 16 outbreaks—primarily in South Carolina (nearly 1,000 cases), Texas, Utah, and Florida—fueling rapid transmission in under-vaccinated communities where 92% of patients are unvaccinated or of unknown status. This surge, accelerated by the virus's high basic reproduction number (12-18), marks the fastest growth since 1992, surpassing early-year records and risking loss of U.S. measles elimination status. Hospitalizations stand at 5% with no deaths. Traders should watch weekly CDC updates (next expected early April) and state vaccination campaigns, as ongoing outbreaks could add hundreds more cases by April 30 resolution.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы